Plain-English translation of NCT06767332 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a therapy called Eye Movement Desensitization and Reprocessing (EMDR) to help people with familial melanoma who struggle with intense fear that their cancer will return. EMDR is an established treatment for trauma and anxiety that works by helping your brain process distressing memories and worries. Researchers want to see if this therapy can reduce fear of recurrence and improve quality of life for people carrying a familial melanoma diagnosis.
Many people with familial melanoma experience high levels of fear about developing new melanomas, which affects their daily life and emotional wellbeing. While some worry is normal and helpful, this study exists because current treatments don't adequately address the deep-seated fear and anxiety that about one-third of patients struggle with, and this therapy has shown promise in other anxiety conditions.
You likely qualify if…
You likely don't qualify if…
If you're assigned to receive treatment immediately, you'll have an initial 90-minute session plus up to four additional 90-minute therapy sessions with a trained EMDR therapist. You'll complete questionnaires about your fear and quality of life before treatment starts, after your last session, and again at 2 weeks and 3 months after finishing. If you're assigned to the waiting list, you'll wait 6 weeks before receiving the same treatment and completing the same assessments.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Netherlands